Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Cancer Res. 2011 Jan 14;71(5):1904–1911. doi: 10.1158/0008-5472.CAN-10-3430

Figure 2. Bisulfite genomic sequencing shows that SG treatment leads to decreased methylation at CpG sites in the predicted promoter region and/or the first exon of genes.

Figure 2

(A) PCDHGA12; (B) RPIB9; (C) Asparaginase; (D) DCC. Each square represents a single CpG site. The number of rows designates the number of the colonies sequenced. White and black squares represent unmethylated and methylated CpGs, respectively. The percentage of CpG methylation is listed underneath each figure.